ATEC Quote, Financials, Valuation and Earnings

Tactile Systems Technology, Inc. has a net margin of -14.54% compared to Alphatec Holdings, Inc.'s net margin of 9.57%. Alphatec Holdings, Inc.'s return on equity of -1495.13% beat Tactile Systems Technology, Inc.'s return on equity of 8.82%.

Alphatec Holdings, Inc. has a consensus price target of $23.92, signalling upside risk potential of 12.66%. On the other hand Tactile Systems Technology, Inc. has an analysts' consensus of $18.83 which suggests that it could fall by -8.95%. Given that Alphatec Holdings, Inc. has higher upside potential than Tactile Systems Technology, Inc., analysts believe Alphatec Holdings, Inc. is more attractive than Tactile Systems Technology, Inc..

Alphatec Holdings, Inc. has a beta of 1.081, which suggesting that the stock is 8.127% more volatile than S&P 500. In comparison Tactile Systems Technology, Inc. has a beta of 0.931, suggesting its less volatile than the S&P 500 by 6.902%.

Alphatec Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tactile Systems Technology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings, Inc. pays -- of its earnings as a dividend. Tactile Systems Technology, Inc. pays out -- of its earnings as a dividend.

Alphatec Holdings, Inc. quarterly revenues are $196.5M, which are larger than Tactile Systems Technology, Inc. quarterly revenues of $85.8M. Alphatec Holdings, Inc.'s net income of -$28.6M is lower than Tactile Systems Technology, Inc.'s net income of $8.2M. Notably, Alphatec Holdings, Inc.'s price-to-earnings ratio is -- while Tactile Systems Technology, Inc.'s PE ratio is 34.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings, Inc. is 4.32x versus 1.99x for Tactile Systems Technology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -14.54% compared to Alphatec Holdings, Inc.'s net margin of -862.39%. Alphatec Holdings, Inc.'s return on equity of -1495.13% beat VolitionRX Ltd.'s return on equity of --.

Alphatec Holdings, Inc. has a consensus price target of $23.92, signalling upside risk potential of 12.66%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.50 which suggests that it could grow by 779.04%. Given that VolitionRX Ltd. has higher upside potential than Alphatec Holdings, Inc., analysts believe VolitionRX Ltd. is more attractive than Alphatec Holdings, Inc..

Alphatec Holdings, Inc. has a beta of 1.081, which suggesting that the stock is 8.127% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Alphatec Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Alphatec Holdings, Inc. quarterly revenues are $196.5M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Alphatec Holdings, Inc.'s net income of -$28.6M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Alphatec Holdings, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings, Inc. is 4.32x versus 19.49x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -14.54% compared to Alphatec Holdings, Inc.'s net margin of -1037.17%. Alphatec Holdings, Inc.'s return on equity of -1495.13% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Alphatec Holdings, Inc. has a consensus price target of $23.92, signalling upside risk potential of 12.66%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than Alphatec Holdings, Inc., analysts believe Catheter Precision, Inc. is more attractive than Alphatec Holdings, Inc..

Alphatec Holdings, Inc. has a beta of 1.081, which suggesting that the stock is 8.127% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Alphatec Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Alphatec Holdings, Inc. quarterly revenues are $196.5M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Alphatec Holdings, Inc.'s net income of -$28.6M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Alphatec Holdings, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings, Inc. is 4.32x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -14.54% compared to Alphatec Holdings, Inc.'s net margin of 3.93%. Alphatec Holdings, Inc.'s return on equity of -1495.13% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Alphatec Holdings, Inc. has a consensus price target of $23.92, signalling upside risk potential of 12.66%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 150.92%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Alphatec Holdings, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Alphatec Holdings, Inc..

Alphatec Holdings, Inc. has a beta of 1.081, which suggesting that the stock is 8.127% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Alphatec Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Alphatec Holdings, Inc. quarterly revenues are $196.5M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Alphatec Holdings, Inc.'s net income of -$28.6M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Alphatec Holdings, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 58.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings, Inc. is 4.32x versus 0.65x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.